In the context of hepatic mitochondrial dysfunction, which is associated with increased hepatic FGF21 and GDF15 expression and increased liver-derived GDF15 in the circulation, GDF15 was shown to regulate changes in body and fat mass and protect against hepatic steatosis in DIO but had no effect on glucose disposal. The gene discussed is GDF15; the disease is fatty liver disease.